Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial dysfunction refers to the failure of mitochondria—the cell’s energy-producing organelles—to function normally. This dysfunction can result from genetic mutations, environmental factors, or secondary effects of other diseases. When mitochondria cannot meet the energy requirements of cells and tissues, a wide range of symptoms and disorders may arise. It is implicated in a broad spectrum of diseases, including primary mitochondrial diseases, diabetes mellitus, neurodegenerative disorders, and cardiovascular disease.
Restoring normal bioenergetics; Mitigating oxidative stress; Modulating mitophagy/fusion-fission balance
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial Dysfunction (N/A).